Ibutamoren vs sermorelin: how these two actually compare

Last updated 2026-07-24

what are ibutamoren and sermorelin, and how are they different

Sermorelin is a synthetic analog of growth hormone releasing hormone (GHRH), the first 29 amino acids of the natural hormone that tells the pituitary gland to release its own growth hormone. It's given by subcutaneous injection, usually at night, and it works by activating GHRH receptors on the pituitary. The FDA approved it in 1997 under the brand name Geref for diagnosing and treating growth hormone deficiency in children, and the manufacturer later discontinued the branded product for business reasons, not because of a safety recall ^[1]. That history matters. It means sermorelin has a real FDA drug label, real pharmacokinetic data, and a documented safety file from actual human trials, which almost no other peptide sold today can claim. Ibutamoren, also called MK-677, is a completely different kind of molecule. It's a small, orally active compound that mimics ghrelin, the "hunger hormone," by binding to the growth hormone secretagogue receptor. It stimulates growth hormone and IGF-1 release through a separate pathway than sermorelin does. Ibutamoren has never been approved by the FDA for any use in any country. It has been studied in clinical trials for conditions like frailty in older adults and for reversing muscle wasting, but none of those trials led to approval, and the compound is currently sold online as a "research chemical," not a medicine ^[2]. So the core difference isn't dose or brand, it's category. One is an approved-history injectable peptide drug with a real regulatory pedigree. The other is an unapproved oral compound with no approved use anywhere, sold outside the regulated drug supply. For a full breakdown of what sermorelin does in the body, see sermorelin.

how do ibutamoren and sermorelin work in the body

Growth hormone release from the pituitary is controlled by two opposing signals: GHRH (which turns it on) and somatostatin (which turns it off). Sermorelin only replaces the GHRH signal. It docks onto GHRH receptors on pituitary somatotroph cells and pushes them to release stored growth hormone in a pulse, similar to what the body does naturally overnight ^[3]. Because sermorelin depends on somatostatin still doing its job, the pituitary retains some built-in braking system, at least in theory. That's the basis for why GHRH analogs are thought to produce a more physiologic pulse pattern than direct hormone administration. Ibutamoren works on a different receptor entirely, the growth hormone secretagogue receptor (GHSR), the same one ghrelin uses. Activating GHSR does two things at once: it stimulates growth hormone release and it also drives appetite, which is why ibutamoren reliably increases hunger and, in some study populations, body weight ^[4]. In a randomized trial in older adults, two years of daily oral MK-677 raised fat-free mass modestly but also increased fasting blood glucose and insulin levels, findings the study authors flagged directly ^[4]. Both pathways ultimately raise IGF-1, but the downstream metabolic side effects differ because they're not working through the same receptor system.

how does sermorelin compare to synthetic HGH

This is usually the real question underneath "ibutamoren vs sermorelin," so it's worth answering straight. Synthetic HGH (somatropin) is the actual hormone, injected directly, bypassing the pituitary entirely. Sermorelin is a signal that asks the pituitary to make its own GH. That difference has real consequences. HGH will raise IGF-1 more reliably and by a larger margin because it isn't dependent on a functioning pituitary or intact feedback loops. Sermorelin's effect is capped by how much GH your own pituitary is still capable of producing, which is exactly why it doesn't work well in people whose pituitary is severely damaged or absent. HGH is FDA-approved today for specific indications: adult growth hormone deficiency, HIV wasting syndrome, and short bowel syndrome, among others ^[5]. Sermorelin's own FDA approval as Geref was narrower and is no longer marketed, though the compound is now available through compounding pharmacies under a prescription. Where sermorelin can be the weaker choice: if you need a large, guaranteed rise in IGF-1 quickly, or if you have significant pituitary damage, sermorelin is not going to get you there the way HGH will. Where sermorelin has an edge: it preserves the body's natural pulsatile release pattern and feedback control, so overshoot and some of the fluid retention and joint symptoms seen with HGH dosing are less common, though not zero. Neither drug is approved or has good evidence for anti-aging use, muscle building in healthy adults, or athletic performance, and using either for those purposes is off-label at best.

ibutamoren vs sermorelin: side-by-side comparison

how is sermorelin dosed compared to ibutamoren

Sermorelin dosing in current compounding-pharmacy practice generally runs in the range of 200 to 300 mcg (0.2 to 0.3 mg) per night, injected subcutaneously before bed to align with the body's largest natural GH pulse ^[1][3]. Some prescribers start lower and titrate based on response and IGF-1 labs. Dosing should always come from a prescriber who has reviewed labs and history, not a fixed internet number. Our own sermorelin dosage chart and sermorelin dosage calculator walk through how prescribers typically think about starting doses and titration. Ibutamoren doesn't have an approved dose because it isn't an approved drug. Clinical trials have used doses from about 10 mg to 25 mg once daily by mouth ^[4]. Because it's sold outside the regulated pharmacy supply, product purity, actual dose per capsule, and contamination risk are unverified and vary by seller, a real problem the FDA has flagged for unapproved products marketed with drug-like claims generally ^[6]. That regulatory gap is one of the sharpest practical differences between the two: sermorelin dosing is something a licensed prescriber and pharmacy can standardize and monitor with lab work, while ibutamoren dosing is whatever is printed on a bottle from a supplier with no FDA oversight.

is ibutamoren legal, and is sermorelin legal

Sermorelin is legal to prescribe in the United States. It's available through licensed prescribers and dispensed by compounding pharmacies under a valid prescription, the same regulatory lane used for other compounded peptide and hormone therapies. It carries real FDA history as Geref, even though that specific brand is off the market ^[1]. Ibutamoren has no FDA approval for human use and is not a lawfully marketed dietary supplement under the Federal Food, Drug, and Cosmetic Act's supplement provisions, since it doesn't meet the statutory definition of a dietary ingredient ^[2]. It's also banned by the World Anti-Doping Agency as a prohibited substance in category S2 (peptide hormones, growth factors, and related substances) ^[7]. It's typically sold under "not for human consumption" labeling, which is a legal fig leaf, not a safety endorsement. That labeling exists because the seller is not making a drug claim, not because the product has been tested and cleared for people to take. If legality and oversight matter to you (and they should), that's a meaningful point in sermorelin's favor. A prescription route means a doctor has reviewed your labs and history, and a pharmacy is accountable for what's actually in the vial.

what are the side effects of ibutamoren compared to sermorelin

Sermorelin's documented side effects, drawn from its original clinical trial data as Geref, are mostly local and mild: injection site redness or itching, flushing, headache, and occasionally dizziness ^[1]. Because it works through the pituitary's own feedback loop, runaway overproduction of GH is less likely than with direct HGH administration, though joint discomfort and mild fluid retention can occur, especially at higher-than-typical doses. Ibutamoren's most consistent side effect across studies is increased appetite, which is mechanistically expected given it mimics ghrelin ^[4]. The two-year randomized trial in adults over 60 found statistically significant increases in fasting glucose and a trend toward increased insulin resistance markers with sustained use, alongside swelling in the hands and feet in some participants ^[4]. Because ibutamoren isn't approved or standardized, adverse event reporting outside formal trials is inconsistent, and long-term data in younger, healthy adults using it for bodybuilding or anti-aging purposes essentially doesn't exist. For a longer look at what happens with sermorelin over months to years of use, see sermorelin long-term side effects.

which one actually raises IGF-1 and growth hormone more

In head-to-head terms, ibutamoren's oral, once-daily dosing and 4 to 6 hour half-life produce a more sustained elevation in IGF-1 across the day compared to sermorelin's short nightly pulse ^[3][4]. Sermorelin produces a single overnight pulse that mimics natural physiology more closely but doesn't sustain elevated levels around the clock. Neither of these facts should be read as "more is better." Sustained, non-physiologic elevation of GH and IGF-1 is exactly the pattern associated with the metabolic problems (insulin resistance, edema, joint pain) seen in acromegaly and in some trial data on GH secretagogues ^[4]. A pulsatile pattern that mimics what a healthy pituitary already does, which is what sermorelin aims for, is the more conservative approach, even if the peak numbers look smaller on paper. If your prescriber's goal is a diagnostic or physiologic replacement dose rather than maximal IGF-1 elevation, sermorelin's mechanism is arguably the better fit for that goal, not a weaker version of it.

who is actually a candidate for sermorelin vs ibutamoren

Sermorelin is prescribed off-label in adults for suspected mild growth hormone decline, typically after bloodwork shows low IGF-1, and always by a licensed prescriber who orders labs before and during treatment. It requires a somewhat functional pituitary gland to work at all, since it stimulates rather than replaces GH. Ibutamoren isn't a legitimate prescription option in the United States for any indication. People who use it are, by definition, using an unapproved research chemical outside medical supervision, regardless of what marketing language surrounds the product. That doesn't mean nobody has studied it responsibly. Academic trials on frailty and hip fracture recovery have used it under IRB oversight ^[4], but that's a different situation from buying a bottle online. If you're trying to decide between the two, the honest framing is: sermorelin has a legal, monitored path with a doctor; ibutamoren does not.

what does sermorelin cost compared to ibutamoren

Sermorelin through a licensed prescriber and compounding pharmacy typically runs somewhere in the $150 to $350 per month range in the current US market, depending on dose and pharmacy, though prices vary by region and provider. That price reflects a prescription, physician oversight, and a pharmacy operating under state board of pharmacy rules. Ibutamoren sold online as a research chemical is often cheaper per bottle, but that price comparison is misleading. You're not paying for the same thing: no prescriber review, no lab monitoring, and no verified manufacturing standard. The FDA has specifically warned about unapproved products marketed with drug-like claims outside its oversight, noting that such products have not been evaluated by the FDA for safety or efficacy ^[6]. Cheaper isn't cheaper if what you're buying is unverified. For anyone weighing sermorelin against other options on price and legitimacy, our sermorelin reviews page and sermorelin peptide near me guide cover how to find a legitimate prescriber and pharmacy rather than a gray-market seller.

can you take ibutamoren and sermorelin together

Some online forums suggest "stacking" ibutamoren and sermorelin because they act on different receptors (GHSR versus GHRH receptor) and theoretically produce an additive effect on GH release. There is no published clinical trial testing this combination for safety or effect size in humans. Combining an FDA-history prescription peptide with an unapproved oral compound means your prescriber, if you're using sermorelin under medical care, has no reliable data to predict interactions, dose adjustments, or combined risk to glucose metabolism, fluid balance, or the pituitary axis. Given that ibutamoren alone already raises fasting glucose in trial data ^[4], stacking it with anything that further boosts GH pulses is not something to do without a doctor who knows both compounds are on board, and most legitimate prescribers won't manage an unapproved compound at all. The realistic answer: it's done informally by some people online, it isn't studied, and no licensed prescriber writing you a sermorelin script is going to responsibly co-manage an unregulated research chemical alongside it.

how does sermorelin's FDA history compare to ibutamoren's

This is the clearest, most checkable difference between the two. Sermorelin acetate was approved by the FDA in 1997 under the brand name Geref, indicated for diagnostic testing of growth hormone secretion and for treatment of growth hormone deficiency in children ^[1]. The manufacturer discontinued the branded product some years later for business reasons; the FDA's own record for the application reflects a marketing history rather than a safety withdrawal ^[1]. That's a genuinely rare distinction in the peptide space, where most compounds sold today have never gone through any FDA review at all. Ibutamoren has no FDA approval history whatsoever, in any country, for any indication. It has been studied in academic trials, including a 2-year randomized controlled trial in adults published under PMID 18195335 ^[4], but none of that research led to a marketing approval. It remains classified by regulators as an investigational compound, and the FDA has taken enforcement action against companies selling it as a supplement ^[2]. That asymmetry, one drug with a real approval and discontinuation history, one drug with none, is the single most useful fact for deciding which one to trust more.

Frequently asked questions

What is the main difference between ibutamoren and sermorelin?

Sermorelin is an injectable GHRH analog with FDA approval history (Geref, approved 1997). Ibutamoren (MK-677) is an oral ghrelin-receptor compound never approved for human use anywhere. They work on different receptors, and only sermorelin has a legal prescription pathway in the US.

Is ibutamoren safer than sermorelin?

No good evidence supports that claim. Sermorelin has a documented FDA trial safety record with mostly mild side effects. Ibutamoren trial data show increased appetite, fluid retention, and higher fasting glucose with sustained use, and it's sold unregulated, so purity and dosing accuracy aren't verified.

Is ibutamoren legal in the United States?

Ibutamoren is not FDA-approved for human use and is not legally sold as a dietary supplement; the FDA has taken enforcement action against companies marketing it that way. It's typically sold labeled "not for human consumption." It's also banned by the World Anti-Doping Agency for competitive athletes.

Is sermorelin legal to buy?

Yes. Sermorelin is available by prescription through licensed prescribers and dispensed by compounding pharmacies in the US. It carries real FDA approval history from its original branded version, Geref, approved in 1997 and later discontinued for business, not safety, reasons.

Does sermorelin work as well as real HGH?

Not in raw magnitude. HGH directly replaces the hormone and raises IGF-1 more reliably; sermorelin only stimulates your own pituitary, so results depend on how much GH-producing capacity you still have. Sermorelin preserves natural pulsatile release, which some consider a safety advantage, but it's the weaker option for large, fast IGF-1 increases.

What is Geref and why was it discontinued?

Geref was the FDA-approved brand name for sermorelin acetate, approved in 1997 for diagnosing and treating growth hormone deficiency. The manufacturer discontinued the branded product for business reasons. It was not pulled for a safety failure, and the FDA's own application record reflects a marketing discontinuation.

What does ibutamoren do to blood sugar?

In a 2-year randomized trial in adults over 60, daily oral MK-677 (ibutamoren) significantly increased fasting glucose and showed signs of increased insulin resistance. This is a mechanistic side effect of raising GH and IGF-1 through the ghrelin receptor pathway and is a real concern for sustained use.

Can you stack ibutamoren with sermorelin?

People do this informally online, but no published clinical trial has tested the combination for safety in humans. Combining an unregulated oral compound with a prescription peptide means unknown interaction risk, particularly around blood glucose, and no licensed prescriber will typically co-manage an unapproved research chemical.

How much does sermorelin cost per month compared to ibutamoren?

Sermorelin through a licensed prescriber and pharmacy typically costs roughly $150 to $350 per month depending on dose and provider. Ibutamoren sold online is often cheaper per bottle, but that price doesn't include prescriber oversight, lab monitoring, or verified manufacturing, so it isn't a fair apples-to-apples comparison.

What is the typical sermorelin dose compared to ibutamoren?

Compounded sermorelin is typically dosed around 0.2 to 0.3 mg subcutaneously nightly, based on historic Geref dosing patterns and current compounding practice. Ibutamoren has no approved dose; published trials have used 10 to 25 mg orally once daily, but there's no standardized or regulator-reviewed dosing guide.

Does ibutamoren build muscle better than sermorelin?

Trial data on ibutamoren shows modest increases in fat-free mass in older adults over two years, alongside appetite increases and metabolic side effects. There isn't strong comparative trial data showing it outperforms sermorelin for muscle gain in healthy adults, and neither compound is approved or evidence-backed for bodybuilding use.

Which has more long-term safety data, ibutamoren or sermorelin?

Sermorelin has more real-world regulatory history through its approved use as Geref starting in 1997. Ibutamoren has some multi-year trial data (including a 2-year RCT in older adults) but no approval anywhere and essentially no long-term data in the healthy adults who most commonly buy it online today.

Sources

1. FDA, Geref (sermorelin acetate) Drugs@FDA record, application NDA 019916, approved 1997: Sermorelin was FDA-approved in 1997 as Geref and the branded product was later discontinued for business reasons, not a safety withdrawal
2. FDA, "MK-677 (Ibutamoren): Marketed as a Dietary Supplement Ingredient" enforcement discussion, FDA Dietary Supplement Ingredient Advisory List: Ibutamoren has no FDA approval for human use in any country and is not lawfully marketed as a dietary supplement ingredient
3. Vishnu Priya Veeraraghavan et al., StatPearls, "Physiology, Growth Hormone," NCBI Bookshelf NBK534869: Sermorelin's mechanism as a GHRH analog and its short half-life
4. Nass R, et al., "Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults," Annals of Internal Medicine, PMID 18195335: Sustained oral ibutamoren use increased fat-free mass but also raised fasting glucose and caused fluid retention in trial participants
5. FDA, Drugs@FDA record for Genotropin (somatropin), application NDA 020280: Synthetic HGH is FDA-approved for specific indications including adult GH deficiency and HIV wasting syndrome
6. FDA, 21 U.S.C. 321(ff) definition of dietary supplement and related FDA guidance on unapproved new drugs marketed as supplements: Products marketed as research chemicals or unapproved compounds have not been evaluated by FDA for safety or efficacy
7. World Anti-Doping Agency, 2024 Prohibited List, category S2 peptide hormones, growth factors, related substances and mimetics: Ibutamoren (MK-677) is a banned substance for competitive athletes under WADA's S2 category
8. MedlinePlus, "Human Growth Hormone," National Library of Medicine: Somatropin (HGH) is administered by injection and used under medical supervision for approved growth hormone deficiency indications